Table of Contents
<< Previous Issue | Aug 2022 (Vol: 2022, Issue: 8) | Next Issue >> |
- Section: Licensing
-
Avista Therapeutics Signs Gene Therapy Partnership with Roche for US$1 B
-
Ipsen Enters Immuno-Oncology Partnership with Marengo Therapeutics for US$1.6 B
-
GSK Signs US$1.4 B ADC Option Deal with Mersana
- Section: Mergers & Acquisitions
-
Alcon to Acquire Aerie Pharmaceuticals for US$770 M
- Section: Opinion & Analysis
-
Could Biopharma M&A Activity be on the Rise?
- Section: Research & Development
-
Roche Bolsters Pipeline with Poseida and Kiniksa Deals
-
AbbVie Collaborates with Sosei Heptares to Develop Small Molecules for Neurological Conditions